title: Therapeutic Options for Herpes Simplex Infections.
abstract: Herpes simplex viruses are responsible for a number of disease states in infected individuals. Capable of establishing latent infection, herpes simplex can reactivate, causing pain, discomfort, and psychosocial consequences. Because no cure is available, treatment modalities for herpes simplex infection are required, from both personal and public health standpoints. To date, therapy has centered around the use of antiviral drugs to control infection and suppress recurrences. To expand the scope of available treatments, efforts have focused on the development of vaccines against herpes simplex virus and new agents such as immune response modifiers. Recent data suggest that these new agents are promising in their therapeutic potential.
authors.affiliation: Department of Pharmacology and Therapeutics, The University of British Columbia, Viridae Clinical Sciences Inc.,1134 Burrard Street, Vancouver, BC, Canada V6Z 1Y8. sacks@viridae.com
authors.forename: Eugene
authors.initials: E
authors.lastname: Au
authors.forename: Stephen L.
authors.initials: SL
authors.lastname: Sacks